PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30308035-0	2018	Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.	Metformin	26-35	interleukin 6	Homo sapiens	54-67	
30308035-7	2018	Furthermore, pathway analysis revealed that the metformin-predicted group was characterized by decreased interleukin (IL)-6 pathway signaling, epithelial-mesenchymal transition, and colon cancer metastatic signaling.	Metformin	48-57	interleukin 6	Homo sapiens	105-123	
30308035-10	2018	These findings suggest that blockade of IL-6-induced epithelial-mesenchymal transition is an antitumor mechanism of metformin.	Metformin	116-125	interleukin 6	Homo sapiens	40-44